Citations

Clear

1031 citation(s) found for "Clark, AS".

Bone Research Society Abstracts
Team, the ERC ADREEM, Roelofs, Anke J. , Cummings, Steven R. , Bhimjiyani, A. , Neuburger, Jenny , Gregson, Celia L, Sparkes, Penny C. , Swiatkowska, Agnes, Lelliott, Christopher J. , Williams, Graham R. , Bassett, J. H. Duncan , Paton‐Hough, Julia, Tazzyman, Simon , Evans, Holly , Lath, Darren , Down, Jenny , Green, Alanna, Snowden, John A. , Chantry, Andrew, Na, Harvey, Shepstone, Lee , Kanis, John А. , Lenaghan, Elizabeth, Clarke, Shane, Harvey, I., Heawood, Ali, Howe, Amanda , Marshall, Tarnya, McCloskey, Eugène , Group, the SCOOP Trial, Hardy, Rebecca , Adams, Judith E., Aspden, Richard, Js, Gregory , Vlachopoulo, Dimitris, Maslin, Kate , Gossiel, Fatma , Bishop, Nicholas , Fraser, Robert, Gandhi, Saurabh , Prentice, Ann , Schoenmakers, Inez , Eastell, Richard , Cooper, Cyrus, Group, the MAVIDOS Trial, Ward, Kate, Cooper, Cyrus, Dennison, Elaine, Bonnet, Cleo, Eccles, Emily, Norman, K. Duane, Ko, Jeong‐Hun, Williams, G. Rhys, Madhusudan, Namrata, Bountra, C. , Oppermann, Udo , Oreffo, Richard OC , McEwan, Josephine, White, Kate L. , Oreffo, Richard, Dunlop, D. , Cornish, Jillian , Goring, Alice, Boyde, A. , Hesse, Eric , Olsen, Björn, Pitsilides, Andrew, Oreffo, Richard, Hartley, A M, Fraser, William, Tobias, JS, Harvey, Nicolas, Johansson, Helena , Cooper, Cyrus, Team, SCOOP Study, Roberts, Fiona , Rashdan, Nabil A. , Staines, Katherine, Milne, Elspeth , Morton, Nicholas M. , McCulloch, Kendal, Dunning, Lynette, Lockhart, John C. , Thomas, Neil Peter, Ranganath, L. , Gallagher, James A., Ward, Kate, Stewart, Angela, Garratt, Liz, Bastin, Sonja , Gamble, Gregory D., Shaw, Nick , Prieto-Alhambra, D, Cooper, Cyrus, Hughes, Juliette H. , Liu, Ke , Hughes, Andrew, Nijjar, Jagtar Singh , Padley, Jessica, Poole, Ken, Litwic, Anna, Dennison, Elaine, Edwards, Mark H. , Cooper, Cyrus, Dennison, Elaine, Ishimoto, Yuyu , Cooper, Cyrus, Ntani, Georgia , Yamada, H. , Muraki, Shigeyuki , Yoshida, Munehito , Yoshimura, Tan, Juan, Poole, Kenneth, Larrouture, Quitterie C. , Athanasou, Nick, Al-Sari, Usama , Felder, Alessandro , Chua, Melissa Y, Lodhia, Kalyani, Kłosowski, Michał M. , Farquharson, Colin, Inglis, Stefanie , Redl, Heinz , Oreffo, Richard, Gogakos, Apostolos , Ebri, Davide Komla, Pipelines, Sanger Mouse, Cidonio, Gianluca , Lanham, Stuart , Dawson, Jonathan, Oreffo, Richard, McEwan, Josephine, Wells, Julia, Oka, Hiroyuki , Iidaka, Toshiko , Kodama, Rie , Horii, Chiaki , Nakamura, Kozo, Akune, Toru, Hudson, Katie, Fisher, Matt , Chantry, Andrew, Adoum, Anne‐Tounsia, Bassett, Duncan, Mannan, Naila S., Dewhurst, Hannah F. , Ghirardello, Elena J. , Pipelines, Sangar Mouse, Komla‐Ebri, David, Curry, Katharine F., 𠀉, JH, Ganguly, Payal , Sparkes, Penny, Curry, Katherine F., Sim, Alisia, Kaczynski, Jakub , Novak, Amanda , Mills, David , Bonnet, Cleo, Ihenacho, Menna, Cronin, Rose‐Marie, Mason, Debbie , Rodriguez, Alexander, Xu, Cecilia, Scott, David , Dennison, Elaine, Stephenson, Sonya, Cosulich, Carlotta, Cooper, Cyrus, Sano, Hiroshige, Kondo, Naoki , Shimakura, Taketoshi, Fujisawa, Junichi, Kijima, Yasufumi, Skingle, Linda , Yamamoto, Noriaki , Takahashi, Hideaki E. , Endo, Naoto , Beamish, Rebecca, Evans, Sam, Morgan, Stephanie , Hooper, Kirsty M. , Halewood, Katherine , Stevens, Craig , Staines, Katherine, Steenhuis, Pieter, Ignelzi, Michael A., Morris, Michael D., Karabetsos, Matthew, VanRenterghem, Gloria, Ayyalusamy, Ramamoorthy, Kadamban, Premila, Vaughan‐Lane, Timothy, Wright, Maria da Glória Miotto , Poole, Kenneth , Cooper, Cyrus, Neven, Ellen, Wheeler‐Jones, Caroline , Rukuni, Ruramayi , Crabtree, Nicola , Mukwasi, Cynthia, McHugh, Grace , Gregson, Celia L, Luo, Jin , Dodhia, Vikash , Czekanska, Ewa M., Oreffo, Richard, Arnold, Emily L. , Gohin, Stéphanie , Soper, Robin, Ytrebø, Lars Marius , Meeson, Richard , Howat, D. , Hodges, Stephen , Evelyn‐Wright, Stephanie , Mavrogordato, Mark , Rankin, Kathryn , Stocks, Oliver, Hartley, Chris , Kerslake, R. W. , Thomson, Seamus , Muderis, Munjed Al, Ward, Kevin R. , Sowman, Aneka, Hart, Deborah , Spector, Tim D. , Coxon, Joshua, Townsend, Paul , Jones, Rebecca , Lawrence, Kevin M., Egan, B. T., Tattersall, Luke , Holm, Stefan H. , Martin, Jenny, Saunders, Fiona, Martin, J F, Saunders, Fiona, Davies, Amanda, Hugtenburg, R.P. , Wintsch, Emma, Anderson, Susan, Alshamrani, Hassan A. , Paggiosi, Margaret , Bishop, Nick , Offiah, Amaka C , Pretorius, Sarah, Roberts, Scott, Logan, Malcolm , Allaire, Brett , Bouxsein, Mary , Olatokun, Olamide, Nash, Thomas H., Abdul-Jabar, Hani B., Tran, Anh Nhi, Segeletz, Sandra, McDermott, Emma, Wileman, Tom, Helfrich, Miep , Redman, Amelia, Elford, Carole, Evans, Bronwen, Bradley, Mark , Martín, Iván , Khosla, Sundeep , Mahajan, Sumeet , Heller, Markus O.W. , Schneider, Philipp , Bonewald, Lynda F. , Lillycrop, Karen A. , Hanson, Mark, Lord, Janet M. , Maes, Christa , Ben‐Shlomo, Yoav , Leitch, Victoria D. , Logan, John G. , Croucher, Peter Ian , Lawson, Michelle Anne , Chantry, Andrew , Parsons, Camille M. , Fordham, Richard J , Gittoes, Neil , Holland, Richard , Redmond, Niamh Maria , Peters, T. J. , Torgerson, David John , O’Neill, Terence W , Cooper, Cyrus , Ireland, Alex , Muthuri, Stella G. , Saunders, Fiona R. , Pavlova, Anastasia Vladimirovna , Martin, Kathryn Remmes , Barr, Rebecca J. , Kuh, Diana J. , Cooper, Rachel , BARKER, ALAN ROBERT , Ubago‐Guisado, Esther , Williams, Craig Anthony , Gracia‐Marco, Luis , Curtis, Elizabeth Mary , D’Angelo, Stefania , Moon, Rebecca Jane , Crozier, Sarah , Kennedy, Stephen , Papageorghiou, Aris T. , Fraser, Robert, Inskip, Hazel M. , Godfrey, Keith M. , Javaid, M K , Cooper, Cyrus, Harvey, Nicholas C. , Group, the MAVIDOS Trial, Fuggle, Nicholas R. , Westbury, Leo D. , Syddall, Holly Emma , Ward, Kate, Duggal, Niharika Arora , Bonnet, Cleo Selina , Gilbert, Sophie J. , Norman, Kingsley, Mason, Deborah J. , Pereira, Marie , Petretto, Enrico , Williams, Graham R, Behmoaras, Jacques V. , Andrés, María C. de , Goriainov, Vitali , McEwan, Josephine K, White, Kate, Ferrara, Napoleone, Olsen, Bjorn, Clarkin, Claire E. , Paternoster, Lavinia , Kemp, John P. , Evans, David, TANG, JONATHAN C. Y. , Tobias, Jon H, Gregson, Celia Louise , Harvey, Nicolas, Orriss, Isabel R. , Ahmed, Faisal, Farquharson, Colin , MacRae, Vicky E. , Huesa, Carmen , Hof, Rob vanʼt , Goodyear, Carl S. , Thomas, Neil P. , Jeffery, Nathan S. , Breasail, Mícheál Ó , Reid, Ian R. , Horne, Anne M. , Mihov, Borislav , Bolland, Mark J , Delmestri, Antonella , Pinedo‐Villanueva, Rafael , Wilson, Peter, Hughes, Andrew, Bou–Gharios, George , Ward, Kate, Yamada, Hiroshi, Hashizume, Hiroshi , Tanaka, Sakae , Walker-Bone, Karen E , Knowles, Helen J. , Snelling, Sarah , Tobias, Jon H, Clark, Emma , Doube, Michael , Hutchinson, John R. , Shefelbine, Sandra J. , Dillon, Scott , Nudelman, Fabio , Kanczler, Janos M. , Schneider, Karl H. , Pollard, Andrea S. , Butterfield, Natalie C. , Williams, Graham R, Ahlfeld, Tilman , Glinka, Michael , Kim, Yang‐Hee , Yang, Shoufeng , Gelinsky, Michael , Wells, Julia A. , Kawaguchi, Hiroshi , Fisher, Matt, Miszkiewicz, Justyna Jolanta , Yoshimura, Takashi , Allen, Rebecca S. , El‐Jawhari, Jehan J. , Burska, Agata N. , Ponchel, Frédérique , Giannoudis, Peter Vasilios , Jones, Elena , Komla-Ebri, Davide S. K. , Hohenstein, Peter , Hung, John , Newby, David E. , Baker, Andrew, Karsenty, Gérard , Hsu, Shun‐Neng , Staines, Katherine Ann , Blain, Emma J. , Mason, Debbie, Rodriguez, Alexander, McMillan, Lachlan B. , Srikanth, Velandai , Ebeling, Peter R. , Javaheri, Behzâd , Ferrara, Napoleone, Olsen, Bjorn, Pitsillides, Andrew A. , Jones, Tim J , Clynes, Michael A. , James, Anthony , Harvey, Nicolas, Ersek, Adel , Cosulich, Carlotta Cecilia, Udalova, Irina A. , Horwood, Nicole J. , Jameson, Karen, Dennison, Elaine Margaret , Ayre, Wayne Nishio , Evans, Sam, Morgan, Stephanie, Mandair, Gurjit S. , Kohn, David H. , Kadamban, Premila, Galloway, James Benjamin , Vaughan-Lane, Tim, Wright, Maria, Brassett, Cecilia , Poole, Kenneth, Judge, Andrew , Leyland, Kirsten M. , Bourne, Lucie E. , Patel, Jessal J. , D’Haese, Patrick C. , Majonga, Edith D. , Mujuru, Hilda Angela , Ferrand, Rashida A. , Chen, Jiye , Dawson, Jonathan I. , Geng, Jin , Lim, Khoon S. , Woodfield, Tim B. F. , Greenwood, Charlene , Rogers, Keith D. , McGivern, Hannah , Márquez‐Grant, Nicholas , Zioupos, Peter , Hopkinson, Mark , Howat, David, Williams, Katherine A. , Gostling, Neil J. , Dyke, Gareth J. , Browne, Martin , Woods, Christopher, Dickinson, Alex , Zakrzewski, Sonia , Hartley, Chris, Folland, Jonathan P. , Brooke-Wavell, Katherine S. F. , Ossipov, Dmitri A. , Lu, William W. , Arden, Nigel , Edwards, James R., Kluzek, Stefan , Sanchez-Santos, Maria Teresa , Ismail, Omar Mohammad , Egan, Ben, Birchall, James C. , Heard, Charles, Marchi, Elena De , Virgilio, Francesco Di , Adinolfi, Elena , Gartland, Alison , Moura, Catarina Costa , Tare, Rahul S. , Xavier, Miguel , Beech, Jason Paul , Spencer, Daniel C. , Tegenfeldt, Jonas Olof , Morgan, Hywel , Murphy, Caitlin C. , Gregory, J.S. , Riemen, Anna H.K. , Davies, Amanda, Ahmad, Faizan , Theobald, Peter S. , Johnston, Richard, Piercy, Richard J. , Millar, Sophie , Anderson, Susan, O’Sullivan, Saoirse Elizabeth , Roberts, Scott, Jóhannesdóttir, Fjóla , Anderson, Dennis , Samelson, Elizabeth J , Kiel, Douglas P. , Nash, Thomas, Rochford, Justin J. , Al‐Sabah, Ayesha , Hardy, Rebecca

Mayo Clinic

JBMR Plus | October 2, 2018 | Volume: 2 | Issue: S1 | Pages: No page available

10.1002/jbm4.10073 Get It

HCN1mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyond
Marini, Carla , Porro, Alessandro , Rastetter, Agnès, Dalle, Carine, Rivolta, Ilaria , Bauer, Daniel , Oegema, Renske , Nava, Caroline , Parrini, Elena , Mei, Davide , Mercer, Catherine , Dhamija, Radhika , Chambers, Chelsea , Coubes, Christine, Kuentz, Paul , Julia, Sophie , Pasquier, Laurent , Dubourg, Christèle , Carré, Wilfrid , Melani, Federico , Giardino, Maria , Innes, A. Micheil , Alembik, Yves, Scheidecker, Sophie , Figueiroa, Sónia, Garrido, Cristina , Fusco, Carlo , Spagnoli, Carlotta , Binda, Anna , Granata, Tiziana , Ragona, Francesca , Freri, Elena , Franceschetti, Silvana , Canafoglia, Laura , Castellotti, Barbara , Gellera, Cinzia , Milanesi, Raffaella , Mancardi, Maria Margherita , Clark, Damien R, Helbig, Katherine L. , Ichikawa, Shoji , Sadler, Laurie S. , Neupauerová, Jana, Laššuthová, Petra , Štěrbová, Katalin , Laridon, Annick, Brilstra, Eva H. , Koeleman, Bobby P.C. , Striano, Pasquale, Soblet, Julie , Deconinck, Nicolas , Leguern, Éric , Guerrini, Renzo , Santoro, Bina , Hamacher, Kay , Moroni, Anna , DiFrancesco, Jacopo C. , Depienne, Christel , Guerrini, Renzo , Mei, Davide , Pasquier, Laurent , Thévenon, Julien , Rosati, Anna Maria , Pisano, Tiziana , Santos, Manuela M. , Frattini, Daniele , Clark, Damien R., Kok, Fernando , Lemke, Johannes R. , Zara, Federico , Smits, Guillaume , Barbuti, Andrea , DiFrancesco, Dario , Thiel, Gerhard , Depienne, Christel , Dhamija, Radhika

Mayo Clinic

Brain | September 26, 2018 | Volume: 141 | Issue: 11 | Pages: 3160-3178

10.1093/brain/awy263 | PMID 30351409 Get It

Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory
Ljubenkov, Peter A. , Staffaroni, Adam M. , Allen, Isabel Elaine , Heuer, Hilary W. , Karydas, Anna, Kornak, John , Grinberg, Lea T. , Fagan, Anne M. , Jerome, Gina, Kramer, Joel H. , Miller, Bruce L. , Boxer, Adam L. , Rosen, Howard J. , Boeve, Brad F, Miller, Bruce L , Grinberg, Lea , Rojas, Julio C. , Wang, Ping , Cobigo, Yann , Seeley, William W. , Spina, Salvatore , Knopman, David S. , Boeve, Bradley F. , Dickerson, Bradford Clark

Mayo Clinic

Annals of Clinical and Translational Neurology | September 21, 2018 | Volume: 5 | Issue: 10 | Pages: 1250-1263

10.1002/acn3.643 | PMID 30349860 Get It

AbstractObjectiveThe prognostic value of cerebrospinal fluid neurofilament light chain, total tau, phosphorylated tau181, and amyloid beta1‐42was examined in frontotemporal dementia subtypes.MethodsWe compared baseline biomarkers between 49 controls, 40 patients with behavioral variant frontotemporal dementia, 24 with semantic variant primary progressive aphasia, and 26 with nonfluent variant primary progressive aphasia. Linear mixed effect models were used to assess the value of baseline biomarkers in predicting clinical and radiographic change in patient cohorts over multiple yearly follow up visits.ResultsNeurofilament light chain concentrations were lowest in controls. Elevated baseline neurofilament light chain predicted faster worsening in clinical severity, frontotemporal volume and frontotemporal fractional anisotropy in patients with behavioral variant frontotemporal dementia and nonfluent variant primary progressive aphasia. High total tau similarly predicted faster progression in nonfluent variant primary progressive aphasia. In behavioral variant frontotemporal dementia, higher phosphorylated tau181predicted faster clinical progression whereas lower amyloid beta1‐42predicted faster volumetric and fractional anisotropy reduction. Neurofilament light chain and phosphorylated tau181were of greater predictive value in patients with tau pathology as compared toTDP‐43 pathology. Baseline neurofilament light chain correlated with baseline clinical severity and frontotemporal volume in behavioral variant frontotemporal dementia. Baseline total tau correlated with baseline clinical severity in semantic variant primary progressive aphasia.InterpretationHigh cerebrospinal fluid neurofilament light chain predicts more aggressive disease in behavioral variant frontotemporal dementia and nonfluent variant primary progressive aphasia. Total tau, phosphorylated tau181, and amyloid beta1‐42also predict some measures of disease aggressiveness in frontotemporal dementia.
Thyroidectomy for Amiodarone-Induced Thyrotoxicosis: Mayo Clinic Experience
Kotwal, Anupam , Clark, Jennifer , Lyden, Melanie L. , McKenzie, Travis J. , Thompson, Geoffrey B. , Stan, Marius N. , Lyden, Melanie, McKenzie, Travis , Thompson, Geoffrey , Kudva, Yogish C , Stan, Marius N

Mayo Clinic

Journal of the Endocrine Society | September 6, 2018 | Volume: 2 | Issue: 11 | Pages: 1226-1235

10.1210/js.2018-00259 | PMID 30370394 Get It

Benefit of chemotherapy (CT) in patients (pts) with Merkel cell carcinoma (MCC) with distant metastases (mets) and visceral organ involvement.
Sabol, Angeline J., Otley, Clark C. , Price, Katharine A. , Markovic, Svetomir N.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e21000-e21000

10.1200/jco.2016.34.15_suppl.e21000 Get It

A Prospective Analysis of High-Dose Interleukin-2 (HD IL-2) following PD-1 inhibitor therapy in patients with metastatic melanoma and renal cell carcinoma.
Buchbinder, Elizabeth I. , Perritt, Jessica, Clark, Joseph I. , Curti, Brendan D. , Lao, Christopher D., Fishman, Mayer , Dutcher, Janice P. , Holtan, Shernan G. , Kirkwood, John M. , Kaufman, Howard L. , McDermott, David F.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: e21006-e21006

10.1200/jco.2016.34.15_suppl.e21006 Get It

Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2.
Nanda, Rita , Liu, Minetta C. , Asare, Smita , Hylton, Nola, Veer, Laura van’t, Perlmutter, Jane , Chien, A. Jo , Forero‐Torres, Andres , Ellis, Erin D. , Han, Heather, Clark, Amy S. , Albain, Kathy S. , Berry, Donald A. , Esserman, Laura, Yau, Christina , Wallace, Anne M. , Boughey, Judy C. , Elias, Anthony , Yee, Douglas , DeMichele, Angela

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 35 | Issue: 15_suppl | Pages: 506-506

10.1200/jco.2017.35.15_suppl.506 Get It

506 Background: Pembro is an anti-PD-1 antibody with single agent activity in HER2– metastatic BC. I-SPY 2 is a multicenter, phase 2 platform trial which evaluates novel neoadjuvant therapies; the primary endpoint is pathological complete response (pCR, ypT0/Tis ypN0). We report current efficacy results, with final results at ASCO. Methods: Patients (pts) with invasive BC ≥2.5 cm by exam or ≥2 cm by imaging are assigned weekly paclitaxel x 12 (control) +/- an experimental agent, followed by doxorubicin/cyclophosphamide x 4. Combinations of hormone-receptor (HR), HER2, & MammaPrint (MP) status define the 8 signatures studied. MP low HR+ BC is excluded. Adaptive randomization is based on each arm’s Bayesian probability of superiority over control. Graduation by signature is based on an arm’s Bayesian predictive probability of a successful 1:1 randomized phase 3 trial with a pCR endpoint. We provide raw & Bayesian estimated pCR rates adjusted for covariates, time effects over the course of the trial, & serial MRI modeling for pts not yet assessed for pCR surgically. Results: 69 pts were randomized to pembro (HER2- subsets only) from Dec 2015 until it graduated in Nov 2016. 46 pts have undergone surgery (table); the other 23 have on-therapy MRI assessments. In 29 HR–/HER2– (TNBC) pts, pembro increased raw & estimated pCR rates by >50% & 40%, respectively; in 40 HR+/HER– pts, it did so by 13% and 21%. 5 pts had immune-related grade 3 adverse events (AEs); 1 hypophysitis & 4 adrenal insufficiency. 4 pts presented after completion of AC (149-179 d after starting pembro); 1 presented prior to AC (37 d after starting pembro). 7 pts had grade 1-2 thyroid abnormalities. Conclusion: Pembro added to standard therapy improved pCR rates in all HER2- BCs that meet I-SPY 2 eligibility, especially in TNBC. Immune-mediated AEs were observed; pt follow up is ongoing. Clinical trial information: NCT01042379. [Table: see text]
QUADRA: A phase 2, open-label, single-arm study to evaluate niraparib in patients (pts) with relapsed ovarian cancer (ROC) who have received ≥3 prior chemotherapy regimens.
Miller, David S. , Cloven, Noelle, Hendrickson, Andrea E. Wahner , DiSilvestro, Paul , Cristea, Mihaela , Berek, Jonathan S. , Chan, John K. , Clark, Romnee, Matulonis, Ursula A. , Monk, Bradley J. , Miller, David S , Moore, Kathleen N. , Secord, Angeles Alvarez , Geller, Melissa Ann , Fleming, Gini F. , Azodi, Masoud , Oza, Amit M. , Li, Yong

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 5514-5514

10.1200/jco.2018.36.15_suppl.5514 Get It

Parenteral phenobarbital in status epilepticus revisited: Mayo Clinic experience
Hocker, Sara E. , Clark, Sarah L. , Hocker, Sara, Clark, Sarah, Britton, Jeffrey, Britton, Jeffrey W.

Mayo Clinic

Epilepsia | August 30, 2018 | Volume: 59 | Issue: S2 | Pages: 193-197

10.1111/epi.14488 | PMID 30159873 Get It

SummaryDespite phenobarbital (PB) being a key component in status epilepticus (SE) treatment algorithms for decades, it has fallen out of favor compared to newer nonsedating medications due to potential for respiratory suppression and prolonged sedation. We retrospectively analyzed all nonintubated patients with refractory SE treated with parenteral PB. Forty patients were identified as having received PB in the neurologic intensive care unit at Mayo Clinic over a 7‐year period through our pharmacy dispensing database. Patients who received PB for maintenance therapy, those replenishing subtherapeutic levels, those who were already intubated, and those receiving PB for a non‐SE indication were excluded. Clinical data, prior treatments, therapeutic response, and outcome were reviewed. Eight patients were identified. Ages ranged from 24 to 77 years (median = 64 years); all had focal SE, and none was comatose. Seizure activity improved acutely following PB administration in seven and stopped in six. Dosages ranged from 5 to 19.8 mg/kg (median = 10.1 mg/kg); none required intubation, and one received supplemental oxygen. Patients received a median of four antiepileptic drugs prior to PB. Median interval between first drug and PB was 23.5 hours. Glasgow Coma Scale score did not change following PB administration. One patient required intervention for hypotension. Moderate‐dose parenteral PB was effective in attaining seizure control in a significant proportion of noncomatose refractory SE patients. None required ventilatory support. PB dosages below those in recent guidelines may be sufficient to stop SE without clinically significant cardiopulmonary complications.
Etiologies and characteristics of refractory status epilepticus cases in different areas of the world: Results from a global audit
Ferlisi, Monica , Hocker, Sara E. , Trinka, Eugen , O’Brien, Terence J. , Cook, Mark , Leitinger, Markus , Newton, Charles R. , Giovannini, Giada , Hocker, Sara, Cook, Mark J , Trinka, Eugen , Shorvon, Simon D.

Mayo Clinic

Epilepsia | August 30, 2018 | Volume: 59 | Issue: S2 | Pages: 100-107

10.1111/epi.14496 | PMID 30159876 Get It

Summary To describe the demographics, etiologies, types of status epilepticus ( SE ), and outcomes in people with refractory and super‐refractory SE from around the world, we prospectively collected cases of refractory SE ( RSE ) treated with continuous intravenous anesthetic drugs in an intensive care unit setting through online questionnaires using “active surveillance.” We collected information about 776 cases of RSE in 50 countries over 4 years. Control of SE was achieved in 74% of the cases. Neurologic outcomes were poor in 41% of patients, and 24% died. Good outcome was associated with younger age and a history of epilepsy. Etiology strongly influenced the outcome. Patients from Asia were younger, more frequently presented with convulsive SE , and were more frequently affected by infectious etiologies when compared with patients from Europe and the Americas. Despite these differences, outcomes were similar in all countries. Demographics of patients with RSE in a global audit are similar to those in prior single center series, providing evidence of generalizability of those studies. Important differences exist among patients with RSE from different regions of the world, but these do not seem to significantly influence patient outcomes.